Chairman John Moolenaar (R-MI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party called for a federal inquiry into whether TikTok violated the Children’s Online Privacy Protection Act, other laws, or its own terms of service when the company fed deceptive information to American children and used them to lobby Congress.

Chairman Mike Gallagher (R-WI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition between the United States and the Chinese Communist Party (CCP) today unveiled the findings of their bipartisan investigation into the world’s foremost index provider, MSCI., and the world’s largest asset manager, BlackRock. The investigation also included a canvass of the broader U.S.

Chairman Mike Gallagher (R-WI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party wrote to Secretary of State Antony Blinken, urging the State Department to increase diplomacy to ensure companies profiting off the CCP’s ongoing genocide in Xinjiang are not able to access global markets.

WASHINGTON, D.C. — Today, Chairman Mike Gallagher (R-WI) and Ranking Member Raja Krishnamoorthi (D-IL), Chairman and Ranking Member of the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party, sent a letter to Secretary Antony Blinken and Secretary Pete Buttigieg urging the officials to be cautious when approving new flights between the United States and the People’s Republic of China, citing unfair market practices and security concerns.

Chairman Mike Gallagher (R-WI) and Ranking Member Raja Krishnamoorthi (D-IL) of the House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party wrote to Secretary of Defense Lloyd Austin, alerting him that a Chinese military company, BGI, is attempting to set up a new firm, Innomics, in Massachusetts and Kentucky, to avoid regulatory scrutiny. The lawmakers also identify other problematic Chinese biotech companies in the U.S.